Skip to Main Content

NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

Policy Advocacy Team

From taxes to transportation and energy to workers’ compensation,...

Bioscience

Connecticut Bioscience Growth Council

The Connecticut Bioscience Growth Council consists of representatives from...

Bioscience

Don’t Change What’s Working, Says Boehringer VP

Want to see one example of where state tax...

Bioscience

Federal Patent Troll Proposal Still Has Wrinkles

Soon after the Connecticut General Assembly finished the 2015...

Bioscience

Biopharma Sees Hard Times in 2015 Session

“It was the best of times, it was the...

Bioscience

Tax, Spending Hikes: What the Papers Say

Editorial writers at Connecticut’s daily newspapers are almost universal...

Bioscience

We Can Do Better

At the time of this writing, just a few...

Bioscience

Biopharma Seeing Cloudy Future

Biopharma could be the most future-oriented industry of all....

Bioscience

CBIA

Manufacturing & Technology Day Thanks

Thanks to the Connecticut manufacturers and organizations who made...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.